GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moleculin Biotech Inc (LTS:0K2H) » Definitions » Other Assets for Insurance Companies

Moleculin Biotech (LTS:0K2H) Other Assets for Insurance Companies


View and export this data going back to 2018. Start your Free Trial

What is Moleculin Biotech Other Assets for Insurance Companies?

Other Assets for Insurance Companies only applies to insurance companies.


Moleculin Biotech Business Description

Industry
Traded in Other Exchanges
Address
5300 Memorial Drive, Suite 950, Houston, TX, USA, 77007
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.